Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : C3 ( CTHR ) Diamond in the rough? -- Ignore unavailable to you. Want to Upgrade?

To: Leslie S. Feinberg who wrote (37)	12/31/1997 1:28:00 PM
From: Ceebs Hartmann	Read Replies (1) \| Respond to of 226

I bought some today. Think it is a great buy here down on fairly light volume. Think this company has potential to totally change diamond business and with a market cap of $79 million I think it is a great buy. Several recent stories on ABC and Discovery exposing that gemologists are unable to tell the difference. If nothing else market for testing device should be huge and immediate. Lastly, insider buying -- Insider Buys C3 INC. Stock 12/17/97 Select Federal Filings Newswires (Copyright (c) 1997, Dow Jones & Company, Inc.) FORM 4 ISSUER: C3 INC. SYMBOL: CTHR FILER: SYKES OLLIN B TITLE: Director PURCHASED: 11/14/97-11/19/97 22,300 14.63-15.00 OWNERSHIP: 103,512 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - (END) FEDERAL FILINGS-DOW JONES NEWS 12-17-97 05:17